HealthTech

GOP Seeks to Drastically Cut Medicaid Spending — How Ar...

House Republicans introduced a proposal seeking to cut Medicaid spending by hund...

Ex-DeepMind scientist launches AI biotech Latent Labs w...

Simon Kohl turned an internship at Google DeepMind into a key role in building A...

Candid Health Raises $52.5M for Autonomous Revenue Cycl...

What You Should Know:  – Candid Health, a provider of autonomous revenue cycle a...

FDA Approval of Drug for Rare Tumors Enables SpringWork...

SpringWorks Therapeutics’ Gomekli is now FDA approved for treating tumors caused...

Novo's weight loss drug helps curb some drinking habits...

New research from the University of North Carolina-Chapel Hill found that Novo N...

NIH’s funding cut plan poses challenges for researchers...

An NIH cap on indirect cost payments for grant recipients is casting a shroud of...

Kaiser Permanente calls on FDA and Congress to firm up ...

While FDA is implementing new accelerated approval reforms, Kaiser Permanente sa...

31% of America’s Workforce and Families Have Cardiac Di...

What You Should Know:  – A new analysis of U.S. heart health trends reveals a co...

Keragon Secures $7.5M for AI-Powered Healthcare Automat...

What You Should Know: – Keragon, an AI-powered, HIPAA-compliant automation platf...

Human-Generated Data: The Missing Link in AI-Powered Re...

Mounting financial pressures for healthcare organizations mean sustainability hi...

Survey: 83% of Clinical Data Abstractors Believe AI Can...

What You Should Know:  – Carta Healthcare, a provider of clinical data solutions...

Biogen downplays capacity for M&A; Roche’s SMA drug is ...

Plus, news about Odyssey Therapeutics, GSK, Aligos Therapeutics, Terrain Bioscie...

What CVS is doing about high medical costs

CVS Health ended 2024 as it started, with high medical costs in the company’s in...

Pfizer wins approval in new indication for blood cancer...

Pfizer secured an eighth indication for its blood cancer drug Adcetris after the...

Centivo, Premise Health Strike Partnership to Create Pr...

Centivo and Premise Health are launching a new primary care-focused health plan ...

AnaptysBio gets a mid-stage win for PD-1 drug in rheuma...

AnaptysBio trumpeted a Phase 2b success in rheumatoid arthritis Wednesday mornin...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.